Table 2.
CT Modality | Effective Dose (mSv) | Additional Risks |
---|---|---|
CACS | 1.0–1.5 | - |
CCTA | <1.0–13.5 | Contrast-related, Beta-blockers/Nitroglycerine |
FFR-CT | <1.0–13.5 | Contrast-related, Beta-blockers/Nitroglycerine |
Stress-CTP | 2.5–21.6 | Contrast-related, Beta-blockers/Nitroglycerine, Adenosine |
CT: computed tomography; CCTA: coronary computed tomography angiography; FFR-CT: fractional flow reserve derived from computed tomography; CTP: computed tomography perfusion.